Novavax (NASDAQ:NVAX) shares fell on Tuesday after Citi started its coverage of the COVID shot maker with a Sell recommendation and a price target of $6, citing among other issues concerns over the ...

(In the weekly Health Matters newsletter, Ramya Kannan writes about getting to good health, and staying there. You can ...

The budget cuts threaten global progress on everything from heart disease to H.I.V. — and could affect American drug ...

COVID-19 appears to be on the rise in some parts of California as a new, highly contagious subvariant — featuring “razor ...

Although vaccines may have a tougher time winning the endorsement of the CDC's Advisory Committee on Immunization Practices ...